Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 17Withdrawn 2Terminated 2Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 84Ovarian Neoplasms 35Breast Neoplasms 31Lung Neoplasms 28Uterine Cervical Neoplasms 17Triple Negative Breast Neoplasms 15Fallopian Tube Neoplasms 15Carcinoma, Ovarian Epithelial 15Small Cell Lung Carcinoma 14Squamous Cell Carcinoma of Head and Neck 10Neuroblastoma 10Esophageal Neoplasms 9Esophageal Squamous Cell Carcinoma 8Central Nervous System Neoplasms 8Recurrence 6Head and Neck Neoplasms 6Endometrial Neoplasms 6Retinoblastoma 5Neoplasm Metastasis 5Brain Neoplasms 5Adenocarcinoma of Lung 5Testicular Neoplasms 3Oligodendroglioma 3Neoplasms 3Melanoma 3Medulloblastoma 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Glioblastoma 3Carcinoma, Squamous Cell 3

Interventions

Doxorubicin 19Radiotherapy 10Ifosfamide 10apatinib 9anlotinib 8Cyclophosphamide 8camrelizumab 7Vincristine 5Dactinomycin 5toripalimab 3Trabectedin 3Radiation Dose Hypofractionation 3Etoposide 3Docetaxel 3ribociclib 2brostallicin 2Topotecan 2Thalidomide 2Temozolomide 2Sorafenib 2Oncolytic Virotherapy 2Nivolumab 2Neoadjuvant Therapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ipilimumab 2Immune Checkpoint Inhibitors 2Gene Expression Profiling 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Sarcoma × Carboplatin × Clear all
NCT00379457 2013-08-12

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
600 enrolled
Sarcoma

Malignant mesenchymal tumor, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡